Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Geron Corporation    GERN

Delayed Quote. Delayed  - 06/24 10:00:04 pm
2.59 USD   -5.82%
05/06 GERON : reports 1Q loss
05/05 Geron Corporation Reports First Quarter 2016 Financial Results an..
04/27 Geron Announces Conference Call to Discuss First Quarter 2016 Fin..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/20/2016 06/21/2016 06/22/2016 06/23/2016 06/24/2016 Date
2.8(c) 2.68(c) 2.67(c) 2.75(c) 2.59(c) Last
2 411 462 1 975 287 1 357 056 1 116 832 2 405 962 Volume
+2.56% -4.29% -0.37% +3.00% -5.82% Change
More quotes
Financials ($)
Sales 2016 1,65 M
EBIT 2016 -42,0 M
Net income 2016 -39,1 M
Debt 2016 -
Yield 2016 -
Sales 2017 48,1 M
EBIT 2017 2,51 M
Net income 2017 3,18 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 250x
Capi. / Sales2017 8,56x
Capitalization 412 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park,... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
05/06 GERON : reports 1Q loss
05/05 Geron Corporation Reports First Quarter 2016 Financial Results and Recent Eve..
04/27 Geron Announces Conference Call to Discuss First Quarter 2016 Financial Resul..
04/20 Geron Announces Two Imetelstat Poster Presentations at the American Associati..
04/06 GERON : to Present at the Needham Healthcare Conference
04/05 Geron to Present at the Needham Healthcare Conference
03/30 GERON CORPORATION : Why Investors Are So Bullish on This Small Biotech
03/17 Geron Announces Presentations at American Association of Cancer Research Annu..
03/02 GERON CORPORATION : (NASDAQ: GERN) Favorable Financial Results and Positive Guid..
02/26 GERON : reports 4Q loss
More news
Sector news : Bio Therapeutic Drugs
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
06/24 MEDIVATION : Glass Lewis Recommends Medivation’s Stockholders Support the ..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
06/24 Is Jakafi A Breakthrough For Incyte In Blood Cancers?
06/03 Is It Time To Invest In Stem Cell Biotechs?
06/01 The Outlook For Geron Corporation's Oncology Program
05/31 A Milestone Event In Geron's Imetelstat Phase II Study For Myelofibrosis Pati..
05/05 Geron's (GERN) CEO John Scarlett on Q1 2016 Results - Earnings Call Transcrip..
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions